SHUKRAPHAR quarterly results and annual financials: sales, operating profit, OPM, net profit, EPS, balance sheet, cash flow and ratios like ROCE, with YoY and QoQ growth.
Shukra Pharmaceuticals Ltd reported sales of ₹24 Cr, operating profit of ₹19 Cr (OPM 81%) and net profit of ₹13 Cr for the quarter ended Jun 2026. Figures in ₹ crore, consolidated where available.
SHUKRAPHAR quarterly results (₹ Cr)
Metric
tooltips
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Sales
-
11
13
5
6
39
6
24
YoY Sales growth
-
-
-
-
-
270
-52
336
Expenses
-
7
6
4
6
12
6
4
Operating Profit
-
4
7
1
0
27
1
19
OPM
-
37%
55%
24%
-7%
69%
11%
81%
Other Income
-
1
1
1
2
1
1
1
Interest
-
0
0
0
0
0
0
0
Depreciation
-
1
1
1
1
1
1
1
Profit before tax
-
4
8
1
0
27
0
18
Tax
-
23%
29%
26%
-1,090%
24%
553%
29%
Net Profit
-
3
5
1
2
20
-2
13
EPS in Rs
-
0.07
0.12
0.02
0.05
0.46
-0.04
0.29
SHUKRAPHAR profit & loss, annual (₹ Cr)
Metric
tooltips
Mar 2025
Mar 2026
TTM
Sales
-
33
57
75
Sales growth
-
-
74
-
Expenses
-
20
28
28
Operating Profit
-
13
29
47
OPM
-
39%
51%
62%
Other Income
-
4
5
4
Interest
-
1
1
1
Depreciation
-
3
3
4
Profit before tax
-
13
29
46
Tax
-
28%
23%
-
Net Profit
-
10
22
34
EPS in Rs
-
0.22
0.5
0.76
Dividend Payout
-
5%
2%
-
SHUKRAPHAR balance sheet (₹ Cr)
Metric
Mar 2025
Mar 2026
Equity Capital
44
44
Reserves
19
46
Borrowings
4
5
Other Liabilities
20
23
Total Liabilities
87
117
Fixed Assets
19
22
CWIP
2
12
Investments
0
0
Other Assets
65
84
Total Assets
87
117
SHUKRAPHAR cash flows (₹ Cr)
Metric
Mar 2025
Mar 2026
Cash from Operating Activity
8
3
Cash from Investing Activity
-1
-14
Cash from Financing Activity
-5
5
Net Cash Flow
2
-6
Free Cash Flow
5
-13
CFO/OP
92%
19%
CFO/EBITDAShare of operating profit converting into cash: CFO (before tax) / Operating Profit